Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Epidemiology and risk factors

05.09.2005


The fact that cardiovascular disease (CVD) is the number one killer of European women is still not widely known, nor is that women are disadvantaged in terms of risk assessment, diagnosis, prognosis and treatment.



CVD is the biggest cause of death in European women, accounting for 40% of all deaths- twice as much as all cancers combined. Coronary heart disease (CHD) and stroke together are TEN times commoner than breast cancer, yet many women -and indeed health professionals- appear unaware of this.

Risk of cardiovascular disease in both sexes is related to age, smoking, blood cholesterol level and blood pressure; while women develop CVD ten years after men, it is more lethal when it occurs one year after a heart attack (42% of women will be dead, compared to 24% of men). A woman with multiple risk factors loses her "age advantage" and may be at higher risk than a man the same age. Diabetes is a particularly potent risk factor in women.


Diagnosis and Treatment

Women are less likely to be investigated for heart disease, diagnosed correctly, referred for specialist investigation, offered revascularization, have adequate risk factor assessment or be offered appropriate drug therapy such as aspirin, beta-blockers and cholesterol lowering medication. They are seriously under-represented in therapeutic trials, resulting in a less adequate evidence base for treatment.

New Points from the Conference

  • Women are less likely to be offered percutaneous interventions (angioplasty and stents) than men and do less well when they do receive them. Underutilization of drug treatments has been confirmed.
  • Young female diabetics are at high risk, and have a disproportionately high mortality when they do get a heart attack.
  • Women who have an out of hospital cardiac arrest are less likely to survive than men.
  • Women with chest pain and apparently normal coronary arteries on coronary angiography may have severe atherosclerosis when assessed with intravascular ultrasound (IVUS). They develop more acute coronary syndromes (heart attacks and unstable angina) over follow-up than men.

Conclusions

There is a major need to communicate these findings to the public, health planners and indeed health professionals. More research is needed into the clinical presentation of CVD in women and why health professionals and indeed perhaps women themselves seem to underestimate the problem. Therapeutic trials planners need to recognize that CVD is, if anything, a bigger problem for women than men. New detection and management strategies are needed, and new recommendations on CVD evaluation, prevention and management need to reflect this new knowledge. Ultimately, as with all aspects of CVD prevention, the challenge is to "de-medicalise" the problem and make self risk assessment and management accessible to all from childhood on.

Gina Dellios | alfa
Further information:
http://www.escardio.org/vpo/ESC_congress_information/ConferenceReleases/

More articles from Health and Medicine:

nachricht Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur

nachricht MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Fraunhofer ISE Pushes World Record for Multicrystalline Silicon Solar Cells to 22.3 Percent

25.09.2017 | Power and Electrical Engineering

Usher syndrome: Gene therapy restores hearing and balance

25.09.2017 | Health and Medicine

An international team of physicists a coherent amplification effect in laser excited dielectrics

25.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>